Bionics+: User Centred Design and Usability of Bionic Devices

Bionics+ NetworkPlus将代表EPSRC物理干预前沿大挑战主题中仿生技术的研究，临床和工业社区。它将振兴和支持一个有凝聚力、开放和积极的网络，其使命是创造一个相互支持的环境。它将导致共同创造以用户为中心的仿生解决方案，适合目的。这些进步将产生全球影响，巩固英国的世界领先地位。创始阶段将专注于雄心勃勃的变革性研究，新的合作和转化活动，以及制定长期战略。在此背景下，作为一个社区，我们将探索和确定机会和价值的领域，由仿生用户的需求驱动，补充现有的活动和优势。该网络将鼓励和支持这些优先领域的早期研究，同时提供英国仿生学社区的对外代表和参与。此外，我们的目标是为公共机构，英国工业和政府政策提供咨询服务。在申请时，我们已经获得了大约70个团体的积极承诺，包括仿生用户，来自英格兰，苏格兰，威尔士和北方爱尔兰大学的学术合作伙伴以及一些国际合作伙伴;医疗器械，矫形器和假肢行业的合作伙伴，包括大型企业和中小型公司;以及来自相关NHS诊所和私营部门的许多临床医生，外科医生和对齐的健康专家。

The Bionics+ NetworkPlus will represent the spectrum of research, clinical and industrial communities across bionic technologies within the EPSRC Grand Challenge theme of Frontiers of Physical Intervention. It will invigorate and support a cohesive, open and active network with the mission of creating a mutually supportive environment. It will lead to the co-creation of user-centred bionic solutions that are fit for purpose. These advances will have a global impact, consolidating the world-leading position of the UK. The founding tranche will focus on ambitious and transformative research, new collaborative and translational activities, and the formulation of a longer-term strategy. Within this context, as a community, we will explore and identify areas of opportunity and value, driven by Bionics users' needs, complementary to existing activity and strengths. The network will instigate and support early-stage research in these priority areas, alongside providing an outward-facing representation and engagement of the UK Bionics community. Further, we aim to contribute in an advisory capacity to public bodies, UK industry and government policy. At the time of the application, we have obtained a positive commitment from circa 70 groups including bionic users, academic partners from universities in England, Scotland, Wales and Northern Ireland and a few international partners; partners in medical devices, orthotics and prosthetics industry, both large corporates and small-medium size companies; and many clinicians, surgeons and aligned health experts from relevant NHS clinics and the private sector.